Blueshift Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Blueshift Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,296	Closed	-$161K	–	823
2019 Q4	$161K	Buy	40,296 +7,280	+22%	+$34.2K	0.02%	734
2019 Q3	$162K	Sell	33,016 -2,149	-6%	-$12K	0.02%	649
2019 Q2	$214K	Buy	+35,165	New	+$187K	0.03%	639
2019 Q1	–	Sell	-22,579	Closed	-$304K	–	1011
2018 Q4	$304K	Buy	+22,579	New	+$381K	0.06%	486

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Blueshift Asset Management's DPLO Position: Q1 2020 in Review

Blueshift Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 40,296 shares — an estimated $161K sold.

Blueshift Asset Management first reported a position in DPLO in Q4 2018 and held it in 4 quarters. The position peaked at $304K in Q4 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Blueshift Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Blueshift Asset Management sold 40,296 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $161K.
Blueshift Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2018 and held it in 4 quarters.
Blueshift Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $304K in Q4 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Blueshift Asset Management's 13F filing for Q1 2020, filed 14 May 2020.